跳至主要内容
临床试验/NCT06048627
NCT06048627已完成3 期

Clinical Investigation to Assess the Efficacy of an Antimicrobial Mouthrinse in the Reduction of Established Plaque and Gingivitis: a 6-month Clinical Study

Colgate Palmolive1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年3月6日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Whole-mouth Mean Modified Gingival Index (MGI)

研究概览

简要总结

The purpose of this study is to prove whether a fluoride/zinc lactate containing mouthrinse is able to reduce dental plaque and gingival inflammation in patients who have gingivitis when applied twice daily during brushing at home over a period of 12 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Availability for the six-month duration of the clinical research study.
  • Good general health.
  • Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
  • Initial gingivitis index of at least 1.5 as determined by the use of the Gingival Index (Löe 1967).
  • Initial plaque index of at least 1.5 as determined by the use of the Plaque Index (Turesky et al. 1970).
  • Signed Informed Consent Form.

排除标准

  • Presence of orthodontic bands.
  • Malign tumor(s) of the soft or hard tissues of the oral cavity.
  • Antibiotic use any time during the one-month period prior to entry into the study.
  • Participation in any other clinical study or test panel within the one month prior to entry into the study.
  • Dental prophylaxis during the past two weeks prior to baseline examinations.
  • History of allergies to oral care/personal care consumer products or their ingredients.
  • On any prescription medicines that might interfere with the study outcome.
  • An existing medical condition that prohibits eating or drinking for periods up to 4 hours.
  • History of alcohol or drug abuse.
  • Self-reported pregnant or lactating subjects.
  • Participants who have systemic diseases that require regular systemic medication intake that may affect the gingival condition (e.g. antibiotics, phenytoin, nifedipine, cyclosporine, steroids, antiphlogistics).
  • Participants who require antibiotic treatments for dental appointments.
  • Participants with current moderate or severe chronic or aggressive periodontitis (periodontitis screening index [PSI] >2 in more than 2 sextants or PSI >3).
  • Subjects with caries requiring treatment (e.g., caries with cavity) or other oral diseases (including gingival hyperplasia, diseases of the oral mucosa);
  • Smokers or/and users of tobacco products.
  • Persons, who are unable to give their consent (e.g., persons who have limited legal capacity)

研究组 & 干预措施

Mouthwash Test

Active Comparator

干预措施: Amine/zinc lactate/fluoride system (Drug)

Mouthwash Experimental

Experimental

干预措施: negative control (Drug)

结局指标

主要结局

Whole-mouth Mean Modified Gingival Index (MGI)

时间窗: Baseline, 3 weeks, 12 weeks, 24 weeks

Gingivitis, gingival severity and gingival, interproximal scores as measured by the Gingival Index as difference from baseline to 24 weeks between the study groups.

次要结局

  • Intraoral scans(Baseline, 3 weeks, 12 weeks, 24 weeks)
  • Patient-reported experiences(Baseline, 3 weeks, 12 weeks, 24 weeks)
  • Turesky Modification of the Quigley Hein Plaque Index (PI)(Baseline, 3 weeks, 12 weeks, 24 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验